Quality of life in patients with hepatitis C. Importance of treatment
Gastroenterol Hepatol. 2019 Sep:42 Suppl 1:20-25.
doi: 10.1016/S0210-5705(20)30184-9.
Epub 2020 Jun 16.
[Article in
English,
Spanish]
Affiliations
- 1 Servicio de Enfermedades Infecciosas, Hospital Clínic de Barcelona, Barcelona, España. Electronic address: MALLOLAS@clinic.cat.
- 2 Servicio de Aparato Digestivo, Hospital General Universitario Gregorio Marañón, Madrid, España.
- 3 Servicio de Gastroenterología y Hepatología, Hospital Universitario Virgen del Rocío, Sevilla, España; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas; Instituto de Biomedicina de Sevilla, Sevilla, España; Universidad de Sevilla, Sevilla, España.
- 4 Servicio de Enfermedades Infecciosas, Hospital San Pedro, Logroño, España.
- 5 Economista de Salud, Universidad de Castilla-La Mancha, Ciudad Real, España.
- 6 Servicio de Aparato Digestivo, Hospital Clínic de Barcelona, Barcelona, España.
- 7 Servicio de Aparato Digestivo, Hospital Clínico Universitario de Santiago, A Coruña, España.
- 8 Psiquiatría de Urgencias, Hospital Universitario Príncipe de Asturias, Madrid, España.
Abstract
Chronic hepatitis C virus infection is a systemic disease that impairs the quality of life of affected individuals. The impairment is not only due to physiological factors, such as the non-hepatic manifestations of the disease or certain symptoms such as fatigue, weakness and nausea, but is also due to the substantial psychological impact of the infection. Treatment with direct-acting antivirals (DAA) has been demonstrated to substantially improve patient's quality of life, starting in the initial phases. Supplement information: This article is part of a supplement entitled "The value of simplicity in hepatitis C treatment", which is sponsored by Gilead. © 2019 Elsevier España, S.L.U. All rights reserved.
Keywords:
Antivirales de acción; Calidad de vida; Direct-acting antiviral; Health-related quality; Hepatitis C; agents; directa; of life; relacionada con la; salud.
Copyright © 2019 Elsevier España, S.L.U. Todos los derechos reservados.
MeSH terms
-
Antiviral Agents / therapeutic use*
-
Hepatitis C, Chronic / drug therapy*
-
Hepatitis C, Chronic / psychology
-
Humans
-
Quality of Life*
-
Treatment Outcome
-
Work Performance